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Abstract--stChromium-labeled rat pulmonary artery endothelial cells (EC) cultivated 
in MEM medium were killed, in a synergistic manner, by mixtures of subtoxic 
amounts of glucose oxidase-generated H202 and subtoxic amounts of the following 
agents: the cationic substances, nuclear histone, defensins, lysozyme, poly-L-argi- 
nine, spermine, pancreatic ribonuclease, polymyxin B, chlorhexidine, cetyltrimethyl 
ammonium bromide, as well as by the membrane-damaging agents phospholipases 
A2 (PLA2) and C (PLC), lysolecithin (LL), and by streptolysin S (SLS) of group A 
streptococci. Cytotoxicity induced by such mixtures was further enhanced by subtoxic 
amounts either of trypsin or of elastase. Glucose-oxidase cationized by complexing 
to poly-L-histidine proved an excellent deliverer of membrane-directed H202 capable 
of enhancing EC killing by other agonists. EC treated with rabbit anti-streptococcal 
IgG were also killed, in a synergistic manner, by H202, suggesting the presence in 
the IgG preparation of c ross-reactive antibodies. Killing of EC by the various mixtures 
of agonists was strongly inhibited by scavengers of hydrogen peroxide (catalase, 
dimethylthiourea, MnCI2), by soybean trypsin inhibitor, by polyanions, as well as 
by putative inhibitors of phospholipases. Strong inhibition of cell killing was also 
observed with tannic acid and by extracts of tea, but less so by serum. On the other 
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hand, neither deferoxamine, HCIO, TNF, nor GTP3,S had any modulating effects on 
the synergistic cell killing. EC exposed either to 6-deoxyglucose, puromycin, or 
triftupromazin became highly susceptible to killing by mixtures of hydrogen peroxide 
with several of the membrane-damaging agents. While maximal synergistic EC killing 
was achieved by mixtures of H202 with either PLA> PLC, LL, or with SLS, a very 
substantial release of [3H]amchidonic acid (AA), PGE2, and 6-keto-PGF occurred 
only if a proteinase was also added to the mixture of agonists. The release of AA 
from EC was markedly inhibited either by scavengers of H202, by proteinase inhib- 
itors, by cationic agents,by HC10, by tannic acid, and by quinacrin. We suggest that 
cellular injury induced in inflammatory and infectious sites might be the result of 
synergistic effects among leukocyte-derived oxidants, lysosomal hydrolases, cyto- 
toxic cationic polypeptides, pmteinases, and microbial toxins, which might be present 
in exudates. These "cocktails" not only kill cells, but also solubilize AA and several 
of its metabolites. However, AA release by the various agonists can be also achieved 
following attack by leukocyte-derived agonists on dead cells. It is proposed that 
treatment by "cocktails" of adequate antagonists might be beneficial to protect against 
cellular injury in vivo. 
INTRODUCTION 
The mechanisms by which microbial products, complement components, acti- 
vated neutrophils, and macrophages injure and kill mammalian cells in infectious 
and inflammatory sites has been the focus of intensive investigations in the last 
decade (1-13). The idea that target cell killing by some of these agents might 
be the result of "multiple synergistic hits" induced by the combined action of 
microbial hemolysins, antibodies, complement components, and proteinases 
came from our earlier studies with both normal and malignant cells (14-16). 
We have recently also investigated the synergistic killing effects of combinations 
among hydrogen peroxide (H202), cationic polyelectrolytes, phospholipases A2 
and C, a streptococcal hemolysin, and lipoteichoic acid on a variety of cells in 
culture (17-21). Our working hypothesis (21) is that sublethal injuries induced 
in mammalian cells by membrane-damaging agents might be greatly amplified 
by exposure to oxidants and to proteinases. 
The present model further expands our previous observations (17-21) and 
describes the killing of endothelial cells (EC) in culture and the parallel release 
of arachidonic acid and some of its metabolites from cells treated by combina- 
tions of oxidants, phospholipases, cationic agents, a streptococcal hemolysin, 
and proteinases. These agents were chosen because they represent products that 
are likely to be present in inflammatory and infectious sites. To further study 
the possible mechanisms by which these simulated leukocyte- and bacterial- 
derived "cocktails" of agonists kill EC and also degrade their membrane lipids, 
a variety of modulating agents (antioxidants, polyanions, proteinase inhibitors, 
putative inhibitors of phospholipases, antimetabolites) were tested. The possible 
relevance of this in vitro tissue culture model to the events that occur when 
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activated leukocytes induce cell and tissue injury in inflammation will be briefly 
discussed. 
MATERIALS AND METHODS 
Endothelial Cells (EC) 
Rat pulmonary artery endothelial cells (EC) were obtained according to the procedure of Jaffe 
(22) and Ryan and White (23', , employing a minimal essential medium of Eagle with Earl's salts 
(MEM) supplemented with glu:amine, penicillin, and streptomycin as described in detail (17). Upon 
isolation, the cells exhibited the typical cobblestone morphology of endothelial cells. The cell 
monolayers were grown in 24-well plates at 37~ with 5% CO2. All experiments were conducted 
on cells passaged less than 34 times since isolation. 
Labeling of EC with Ck, romium 51. Trypsinized endothelial cells were suspended in MEM 
medium supplemented with 10% FCS containing 1 #Ci/ml of [5~Cr]NaCrO4. The cells were then 
seeded into 24-well dishes (1 ml/well). Following incubation for 24-36 h confluent monolayers 
were obtained. These were washed three times in serum-free MEM medium to remove unbound 
radioactivity. One milliliter of serum-free medium was then added to each well and the plates were 
then used for cytotoxicity assays (see below). 
Labeling of EC with [3H]Arachidonic Acid (AA). Trypsinized endothelial ceils were sus- 
pended in MEM medium supplemented with 10% FCS and 20 t~l of [3H]amchidonic acid (76.0 Ci/ 
mmol) per 100 ml of cell suspension was then added. The ceils were seeded into 24-well plates 
and grown to confluency. 
Cationization of Glucose Oxidase (GO) and Catalase 
Solutions containing either 1 mg/ml of GO (100 units/ml) or 1 mg/ml of catalase (100,000 
units/mg) were rendered cationic by complexing with 1 mg/ml of poly-u-histidine HC1 (tool wt 
23,000) (PHSTD) (24). Brieffr 1 ml of the enzymes was mixed with 1 mg/ml of PHSTD in saline, 
pH 6.0. The mixtures were incubated for 5 min at room temperature to allow complex formation, 
This was followed by the addition of 5 vol of saline buffered with 3 mM HEPES buffer, pH 7.4, 
The opalescent solution that developed was centrifuged for 5 min at 2000 rpm, and the precipitate 
was resuspended in 1 ml saline. Such cationized enzymes retained greater than 95 % of their original 
activities as determined by their ability either to generate hydrogen peroxide in the presence of 
glucose or to destroy its activity (24). The cationized enzymes avidly bound to endothelial cells 
(see below). 
Cytotoxicity Assay 
Cytotoxicity induced by the various agonists was determined by the chromium release method 
described in detail (17, 18). A:; the end of the incubation period specified in the different experiments, 
the cultures were monitored ngicroscopically for altered cell morphology. The amounts of chromium 
298 Ginsburg et al. 
solubilized from the cells were determined following centrifugation of the culture supemates or 5 
min at 2000 rpm in a refrigerated centrifuge. Total radioactivity associated with the cells was 
determined after lysing control monolayers with 1 ml of 1% Triton X-100. In all experiments, the 
amount of radioactivity released in response to treatment was compared with the amounts released 
in cultures incubated with medium alone (spontaneous release). Radioactivity measurements were 
performed in a gamma counter. The release of [3H]AA was determined in a scintillation counter 
employing Scintiverse BD (Fisher) as a scintillation fluid, and the results were calculated as per- 
centage release of radioactivity compared to the total release obtained by treating control wells by 
Triton X-100. It should be noted that the release of more than 40% of the total chromium label 
from EC usually resulted in a near total inhibition of cell replication upon transfer to fresh medium 
(10, 17). 
Measurement of Cyclooxygenase and Lipoxygenase Products 
Supematant fluids obtained from wells treated by the various agents were tested for the content 
of PGE2, 6-keto-PGF, and thromboxane B2 by radioimmunoassay performed by the University of 
Michigan Ligand Core Laboratory and detailed in the publication of Spore et al. (25). Sensitivities 
of the assays were 0.5 pg/100 #1 of supemate for thromboxane B 2 and 2 pg/100 tzl for PGE 2 and 
6-keto-PGF. 
Agents Employed to Kill Cells and Release AA and Its Metabolites 
Hydrogen Peroxide (H202). One milliliter of MEM medium (containing 1 mg/ml of glucose) 
was incubated with 0.2 units/ml of glucose oxidase (100,000 units/g), resulting in the generation 
of approximately 1 mM of H202 after 15 min. Because of glucose limitation, the amounts of peroxide 
generated remained nearly the same even after 2 h of incubation. This amount of GO-generated 
peroxide did not induce the release of any significant amounts of chromium. The method of Thunnan 
et al. (26) was used to quantify the peroxide. 
The following agents were employed to synergize with H202 to kill EC: (A) phospholipase 
A 2 from bee venom (0.1-25 units/ml); (B) lysophosphatidylcboline (lysolecithin, LL) (1-30 /zg/ 
ml); (C) phospholipase C from Clostridium welehii (0.01-0.15 units/ml); (D) streptolysin S (SLS) 
from group A streptococci (1000 units/ml) (27); (E) lipoteichoic acid (LTA) from group A strep- 
tococci (1-100/zg/ml) (19); (F) rabbit anti-streptococcal IgG possessing 39,000 agglutinating units/ 
mg as assayed by passive hemagglutination of human red blood coated by LTA (19); (G) crystalline 
trypsin (10,000-13,000 BAEE units/mg) and pancreatic porcine elastase (40-80 units/mg protein); 
(H) crystalline egg-white lysozyme (56,000 units/mg) and milk lysozyme (100,000-200,000 units/ 
mg); (I) cationic agents nuclear histone (type II-A), poly-L-arginine HC1 (PARG) (mol wt 40,000), 
porcine pancreatic ribonuclease, polymyxin B, chlorhexidine gluconate, cetyltrimethyl ammonium 
bromide (CETAB), spermine, histamine HC1, defensins NP-1 and NP-5 (kindly donated by Dr. M. 
Friedkin from the Weitzman Institute, Rehovot, Israel); (J) hypochlorous acid (HC10), generated 
by the addition of sodium hypochlorite to distilled water at pH 6.0; (K) tumor necrosis factor (TNF) 
(form Genetec); (L) soybean trypsin inhibitor (SBTI). 
The following agents were employed to modulate the killing of EC: catalase, dimethylthiourea 
(DMTU), deferoxamine mesylate, 6-deoxyglucose, pummycin, triflupromazine (TFP), guanosine 
5-O-(3-thiotriphosphate) (GTP3'S), tannic acid, extracts of tea, quinacrine heparin, polyanthole 
sulfonate, and MnCI2. Most of the agents were purchased from Sigma Chemical Co., St. Louis, 
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Missouri. Elastase was from Worthington Biochemical Corporation, Freehold, New Jersey. 
MnC12-4H20 was from Mallin~:krodt Chemical Works, St. Louis, Missouri. 
RESULTS 
Cell Killing 
Combined Effect of Cationic Agents and He02 on EC. Bactericidal cationic 
agents are present in large amounts in granules of PMNs (leukocyte cationic 
proteins, defensins, myeloperoxidase, lysozyme), in eosinophils (major cationic 
proteins), in platelets, in plasma, (/3-1ysins), in saliva (histidine-rich proteins), 
in tears, and in milk (lysozyme) as well as in semen (spermine, spermidine) 
(reviewed in 28). Furthe~maore, large amounts of histones might also be present 
in inflamed sites as a re,;ult of cell death. The likelihood that membrane-dam- 
aging cationic agents (4, 6, 28) might collaborate with oxidants to kill EC was 
further investigated (see 17). 
In a representative 2-h assay, Figures 1 and 2 show the time-course and 
dose-dependent release of chromium, respectively, from monolayers of EC 
treated with different cationic agents combined with GO-generated H202. The 
data suggest that subtoxic concentrations of most of the agents synergized with 
subtoxic concentrations of H202 kill the cells (17, 21). Under similar experi- 
mental conditions only high concentrations either of egg-white or milk lysozyme 
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Fig. 1. Time-course of chromium release from cells treated with hydrogen peroxide and cationic 
agents. Monolayers of  endothelial cells were incubated with histone (100/zg/ml), glucose oxidase 
(GO; 0.2 units/ml with CETAB (10 tzg/ml), or mixtures of GO and the cationic agents, and the 
release of chromium from the cells was determined at intervals. A representative of a typical 
experiment. 
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Fig. 2. Combined effect of cationic agents and hydrogen peroxide on chromium release from EC. 
Monolayers of EC were treated for 2 h at 37~ with increasing concentrations of cationic agents 
in the absence or presence of glucose oxidase (GO; 0.2 units/ml). (A) PMX, polymyxin B sulfate: 
SPRM, spermine HC1, RNAse, pancreatic ribonuclease. (B) PARG, poly-L-arginine; CHEX, chlor- 
hexidine gluconate. The date are the averages of three experiments. 
shown). On the other hand, histamine was totally inactive (not shown). Prelim- 
inary experiments have also shown that two defensins (at 50/~g/ml) also syner- 
gized with H202 to kill EC (50-60% chromium release). In all cases, either 
catalase, DMTU, Mn e§ (see ref. 29), or the anionic polyelectrolytes heparin 
and polyanethole sulfonate totally inhibited cell killing induced by combinations 
of cationic agents and H202 (not shown). 
To determine whether or not the simultaneous presence of both H202 and 
the cationic agents was necessary to induce cell damage, the following experi- 
ments were performed: Cell monolayers were preincubated for 45 min either 
with histone or with GO. The monolayers were then washed to remove unbound 
agent and either GO or histone was then added. Table 1 shows that cells exposed 
to histone and then washed were still damaged upon addition of GO. No such 
phenomenon occurred, however, when the cells were first exposed to GO, 
washed, and then challenged with histone, suggesting that only histone avidly 
bound to the targets and then synergized with H202 to kill the cells. These 
results suggest that both peroxide and histone must be present simultaneously 
in order to exert a synergistic toxic effect on the cells. The presence of either 
catalase (100 units/ml but not heat-inactivated catalase), DMTU (100/zM) or 
Mn 2+ (1 mM) (29) during the incubation period totally inhibited cytotoxicity. 
It was also found that EC that had been precoated either by PHSTD-catalase 
complex (24) or by catalase cationized by the method of Dannon et al. (30) and 
washed were totally refractory to the synergistic toxic effect of added GO + 
histone (see ref. 24). 
Effect of Cationized GO on EC Killing. The synergistic killing induced 
by combinations of cationic agents with hydrogen peroxide also led us to explore 
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the possibility that an enhancement of peroxide delivery to cell surfaces might 
serve as a tool to enhance cell killing. For this purpose GO was complexed to 
PHSTD by the same method employed to cationize catalase (24). Table 2 shows 
that cells pretreated with cationized GO and then washed were readily killed 
upon the addition of histone suggesting that cationization allowed GO to adhere 
to the cell surfaces and to deliver H202 directly to them. To prove that cationized 
GO might also be effective as a tissue-damaging agent in vivo, we instilled GO-  
PHSTD complexes into Lhe trachea of anesthetized rats. In preliminary experi- 
Table 1. Effect of Histone and Glucose Oxidase (GO) on EC Killing ~ 
5~Cr-labeled EC Percent Cr 
pretreated with Followed by Followed by released 
None None Histone (100 t~g/ml) 5 
GO (0.2 units/ml) None None 6 
GO Washing Histone 7 
GO None Histone 56 
Histone None GO 57 
Histone Washing GO 52 
GO + histone None None 55 
aMonolayers of EC were preincubated for 45 rain at 37~ either with MEM alone, GO (which 
yielded approximately 750 nrnol H202 after 45 min of incubation), or histone. Some of the wells 
were washed to remove unbound agent. This was immediately followed by the addition either of 
medium, GO, or histone. Following an additional 1 h of incubation, the supernatant fluids were 
removed and the radioactivi:y solubilized was determined. The data are the average of three 
experiments. 
Table 2. Effect of Cationized Glucose Oxidase (GO) and Histone on EC Killing a 
Percent Cr 
5~Cr-labeled EC pretreated with Followed by Followed by released 
GO (0.2 units/m1) None None 5 
GO Washing Histone (100/xg/ml) 5 
GO None Histone 60 
GO-PHSTD complex (2 unitsJml) None None 5 
GO-PHSTD complex None Histone 60 
GO-PHSTD complex Washing Histone 60 
Histone None None 6 
aEC monolayers were incubw:ed for 45 min at 37~ either with GO or with GO that had been 
complexed with poly-L-histidine (PHSTD) (Materials and Methods). The monolayers were either 
left intact or washed to remove unbound agent. This was immediately followed by the addition 
either of  medium or medium + histone. Sixty minutes later the release of soluble radioactivity 
was determined in the supernatant fluids. The data represent averages of three different experiments. 
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ments (to be published in detail), we found that cationized GO was at least 10- 
fold more toxic to the lung than regular GO. This was determined by measuring 
the index of injury following the leakage into the lungs of systemically admin- 
istered iodine-labeled BSA. Such enhanced lung injury could, however, be totally 
inhibited by administering a mixture of glycine and MnC12 (see ref. 29), which 
scavenged H202. 
Combined Effects of Cationic Agents, 1-1202, and Proteinases on EC. 
Previous studies from our laboratory have described the synergistic killing of 
EC by combinations between proteinases and H202 (18) and between certain 
membrane-active agents and H202 (17, 21). It was therefore also of interest to 
test the combined effect of membrane-active agents, H202, and a proteinase on 
EC. 
As a model, either trypsin or pancreatic elastase were used as representative 
proteinases, CETAB as a cationic agent (because of its resistance to protease 
activity) (see below), and GO as a generator of H202. Figure 3 shows that 
trypsin strongly synergized with GO and with subtoxic concentrations of CETAB 
to release large amounts of the chromium label from the targets. Similar results 
were obtained with elastase (not shown). Thus a triple synergy is more efficient 
than a double synergy in cell killing. The killing effect due to the triple synergy 
was markedly inhibited either by catalase, Mn 2+, heparin, or SBTI (not shown). 
Experiments with histone, however, gave inconsistent results as this cationic 
agent was hydrolyzed by trypsin. To circumvent this problem, we first prein- 
cubated EC with histone to allow binding and "priming" of the cells (see Table 
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Fig. 3. The combined effects of  CETAB hydrogen peroxide and trypsin on endothelial cells. En- 
dothelial cells were exposed for 90 rain at 37~ to increasing concentrations of CETAB, to fixed 
amounts of  GO (0.2 units/ml), or trypsin (100 ~g/ml), to combinations of CETAB, GO, and trypsin 
and to GO and trypsin. A representation of a typical experiment. 
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cells to cytotoxicity following the addition of GO, but no significant further 
enhancement of cell killing occurred upon addition of trypsin, suggesting that 
the protease might have hydrolyzed the cell-bound histone. 
Combined Effect of 11202, PLC, Lysolecithin, and Trypsin on EC. 
Inflammatory sites mighl be rich in exocytosed lysosmal products of leukocytes. 
Thus, target ceils might either become simultaneously or sequentially exposed 
to a multiplicity of hydrolases, cationic proteins, and oxidants (17, 18, 21). It 
was of interest to test wlcLether, as in the case of histone, other agents might also 
irreversibly bind to EC and kill to them in a synergistic manner. Figure 4 shows 
that EC preexposed to sublytic concentrations of PLC (a representative mem- 
brane-damaging agent) ~,nd then washed to remove unbound enzyme were still 
killed in a synergistic manner following the addition of H202. The same degree 
of killing was also ob~;erved if PLC and GO were simultaneously present 
throughout the incubation period. Similarly, cells incubated either with PLAz 
or with SLS (both highly hemolytic and cytolytic) and then washed and exposed 
to GO were also killed in a synergistic manner (not shown), suggesting that 
these membrane-active agents bound to the membrane and continued to exert 
their synergistic action with H202. Experiments performed with PLA2, however, 
necessitated the additio~ of fatty acid-free albumin to remove the cleaved fatty 
acid from the membranes of the EC. 
Experiments on the combined effect of LL and GO on EC killing (see 
Figure 12 below) show(~ that cells exposed to LL for 60 rain, followed by a 
80 
40 PLC* 
-" A -" 
0 L -  , r "  "1 , , , , , , , , , 
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F ig .  4.  The combined  effect of  P L C  and G O  on c h r o m i u m  release f rom EC.  Monolayers  o f  EC 
were  treated for  30 min at 3 7 ~  with increas ing concentra t ions  o f  PLC.  Some of  the monolayers  
were  washed  to remove  unbound  P L C  (*). G O  (0.2 units/m1) was  then added to all the wells,  and  
the release o f  radioact ivi ty  was  determined af ter  a fur ther  incubat ion for  60 min.  Note that EC,  
exposed  to P L C  and washed ,  were  killed to the same degree  as cells incubated with mixtures of  
P L C  and  GO,  sugges t ing  tha~: P L C  firmly bound  to EC and synergized with H202.  The data  are 
the averages  o f  two experiments .  
304 Ginsburg et al. 
wash to remove unbound agent and by the addition of GO, were also killed but 
to a much lower degree (about 25 % release of chromium), suggesting that LL 
must be simultaneously present with H202 to exert its maximal toxic effects (see 
also Figure 14 below). 
EC treated either by mixtures of PLC and peroxide or by SLS and peroxide 
developed, within 15-30 min, large blebs (pseudopodlike structures), usually in 
one pole of the cell. Many of these structures were later found as free-floating 
lipid like droplets (liposomes?). These morphological changes were essentially 
similar to those described either in tumor cells (16) or in epithelial cells exposed 
to similar agonists (21). It is of interest that detachment of the liposomelike 
structures never occurred following exposure of EC either to SLS, PLC, or 
peroxide alone. 
Combined Effects of LTA, Anti-LTA, and 11202 on EC. Previous studies 
have shown that target cells that had been sensitized by LTA derived from group 
A streptococci were killed following the addition of anti-LTA antibodies + 
complement (31-33). In other studies, we have shown that human PMNs sen- 
sitized by LTA and then treated by anti-LTA globulin generated superoxide, 
H202, and chemiluminescence and released a variety of lysosomal enzymes (19). 
The possibility that the presence of LTA-anti-LTA complexes on the surface 
of EC might render them more susceptible to the killing effects of H202 was 
investigated. Monolayers of EC were exposed to LTA (10-100 tzg/ml) for 30 
min to allow cell binding. While LTA-coated EC exposed either to GO or to 
anti-LTA IgG (200/~g protein/ml) were not injured, a very marked release of 
radioactivity (50-60% of total) occurred when the LTA-sensitized EC were 
exposed to mixtures of anti-LTA-IgG and GO. Under similar conditions, non- 
immune rabbit IgG (500 #g protein/ml) failed to cause such an effect. Paradox- 
ically, however, and unexpectedly, EC incubated for 2 h with mixtures of anti- 
LTA IgG and H202 were also killed (50-60% chromium release). The possi- 
bility that the cytolytic effect observed was due to the presence in the anti-LTA 
IgG of antibodies cross-reacting with some epitopes present on the surface of 
EC was considered. Cross-reactivity between microbial antigens and those pres- 
ent in mammalian cells has been extensively studied (see Discussion). To address 
this point, we incubated the anti-streptococcal IgG (1 mg protein/ml) with strep- 
tococci (1 ml of a 10.OD at 550) for 2 h at 37~ and for an additional 24 h at 
4~ to adsorb potential cross-reactive antibodies. The streptococci were then 
removed by high-speed centrifugation, and the supernatant fluid was employed 
to kill EC in the presence of GO. We found that the adsorbed IgG lost 60-70 % 
of its cytotoxicity when combined with sublytic amounts of GO-generated H202. 
In other experiments we first exposed EC to anti-LTA IgG (1 mg protein/ml) 
for 2 h, then washed the cells and treated them with sublytic amounts of per- 
oxide. A significant cytolytic reaction (25-35 % net chromium release) was also 
observed. These experiments suggested that we might be dealing with a novel 
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phenomenon that noncytotoxic antibodies, which might recognize surface com- 
ponents of  EC, became 0ytolytic in the presence of  H202 (see Discussion). 
Modulc!tion of EC Killing by Various Agents 
To further study the mechanisms by which combinations among oxidants, 
membrane-damaging agents, and proteinases kill EC and release membrane 
lipids from these cells (see below),  we tested the modulating effects o~f serum 
proteins, certain metabolic inhibitors, an agent affecting intracellular calcium, 
an analog of  G-proteins,  a transition metal chelator, a cytokine, and an agent 
that coats and denatures cell surfaces (see below). 
EC were preincubated with the various agents for various times and then 
challenged either with GO-generated H202 alone or  with combinations of  per- 
oxide and membrane-damaging agents. 
Effect of 6-Deoxyglucose and Puromycin. EC preincubated for 3 h either 
with 30 mM 6-deoxyglucose (Figure 5) or with 1 mM puromycin (not shown) 
to deplete energy sources and to affect protein synthesis did not become more 
susceptible to kill ing by hydrogen peroxide alone but were killed in a synergistic 
manner (60 % chromium release) by mixtures of  subtoxic amounts of  peroxide 
H/STONE+GO(EC-DEOXY) 60- . ,~  
. .  '~  I. / 7     o c-DEoxY, 
40 
~.~ 20 STONE(EC-DEOXY) 
to i f /  ~ n ,1/ 
~" _ I  = CO~EC-DmXY) n/e."SLS 
0 ~ - " ~  ~ 1 1  , . I I  . II SLS(EC-DEOXY) 
10 20 30 40 50 Histone gg/ml 
20 40 60 80 100 SIS gg/nil 
Fig. 5. Effect of 6-deoxyglucose on killing of endothelial cells by mixtures of H202 with histone 
or SLS. EC were exposed for 3 h at 37~ either to 5 mg/ml 6-deoxyglucose (EC-DEOXY) or to 
medium alone. The cells were then treated with increasing amounts either of histone or streptolysin 
S (SLS) and in the absence or presence of glucose oxidase (0.2 units/ml). Sixty minutes later, the 
release of chromium from the cells was determined. Note that while neither GO-generated hydrogen 
peroxide SLS, nor histone significantly enhanced the killing of deoxyglucose-treated (DEOXY) 
cells, combinations of GO + SLS or GO +histone were highly cytolytic for the deoxyglucose- 
treated cells, The data are the averages of two experiments. 
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and subtoxic amounts of either PLC or of SLS. Our results, however, differ 
from those showing that 6-deoxyglucose inhibited cell killing by defensins (34, 
35). It is also of interest that EC that had been preincubated with 6-deoxyglucose 
did not possess diminished capacities to scavenge H202 (not shown), suggesting 
that the antimetabolite probably did not diminish their cell-associated catalase 
or glutathione peroxidase. 
Effect of GTPTS. Killing of EC by mixtures of poly-L-arginine (PARG) 
and hydrogen peroxide (Figure 2B) was unaffected by pretreatment with GTPTS. 
This agent was found to inhibit killing of targets by PARG (36), presumably 
because this polycation interacted with G-proteins. The possible reason for the 
observations made by Elferink and Deirkauf (36) might be due to the binding 
of GTP3~S (an anion) by PARG (a distinct polycation) but probably not to 
interference with G-proteins. 
Effect of Deferoxamine. The possibility that EC killing by mixtures of 
H202 and the various membrane-damaging agents involved the generation of 
hydroxyl radical via the metal-mediated Haber-Weiss reaction (37), which could 
have killed the cells, was tested by the addition of deferoxamine (3 mM) to the 
reaction mixtures. No modulation of cell killing was observed, however, sug- 
gesting that OH radical might not be involved in EC killing in this model (37). 
Effect of TNF. It is well accepted that TNF is cytotoxic for a variety of 
mammalian cells (38, 39). The possibility that subtoxic amounts of TNF might 
act synergistically with H202 to kill EC was also investigated. TNF (up to 500 
~g/ml), which failed to cause any substantial release of chromium from EC 
after 2 h of incubation, synergized with H202 only to a very small extent (6 _ 
2.0% chromium release, N = 3). It is of interest in this respect that the toxicity 
of TNF to target cells was found to be greatly reduced in the presence of H202 
(40). 
Effect of Hypochlorous Acid. HC10 is a potent cytotoxic oxidant that is 
generated by activated PMNs (41). We, however, found that HC10 at a wide 
range of subtoxic concentrations did not modulate EC killing induced by mix- 
tures of H202 with either PLC or with SLS. 
Effect of Trifluopromazin (TFP). TFP was found to modulate superoxide 
generation induced in PMNs (42, 43). The possibility that interference with 
calmodulin (44) might also alter the susceptibility of EC to killing by mixtures 
of hydrogen peroxide and membrane-damaging agents was therefore investi- 
gated. Figure 6 shows that pretreatment with TFP very markedly enhanced the 
killing of EC either by H202 or by mixtures of hydrogen peroxide and PLC 
Effect of Tannic Acid. Previous publications have shown that tannic acid 
modulated several leukocyte functions (45-47) and bacteriolysis (48). The de- 
naturing activities of tannic acid and of extracts of tea, known to be rich in this 
acid, was also investigated in the EC model. We found that coating of EC either 
by noncytotoxic amounts of tannic acid (10-5-10 -4 M) or by 10-100 /zl of 
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Fig. 6. Effect of triflupromazine (TFP) on killing EC in the presence of PLC and GO. EC 
monolayers were exposed for t20 rain at 37 ~ to increasing concentrations of TFP. The cells were 
then further exposed for an additional 60 minutes either to GO (0.2 units/ml), PLC (0.05 units/ml), 
or mixtures of PLC and GO. The data are the averages of three experiments. 
extracts of black tea (1 g of tea brewed with 10 ml of boiling water), followed 
by a cell wash, caused 95 % inhibition of chromium release from EC exposed 
to mixtures of H202 either with PLC or with SLS (not shown). The same 
amounts either of tannic acid or tea also very markedly inhibited lysis of human 
RBC induced either by SLS or by PLC. Our findings suggest, therefore, that 
coating by tannic acid, which alters cell surfaces, might also affect other cell 
types (e.g., epithelial cells in the gut), protecting them against microbial toxins 
and leukocyte hydrolases. 
Effect of Serum Proteins and Inhibitors. The possibility that serum pro- 
teins might modulate EC killing by mixtures of oxidants and membrane-dam- 
aging agents was also investigated. Figures 7 and 8 show that larger amounts 
of either CETAB or histone were necessary to kill EC in the presence of H202 
and 10% fetal calf serum. Inhibition by serum proteins might be due to albumin 
(a polyanion), which bound the cationic agents employed. On the other hand, 
serum at the same conce, ntration caused only about 25 % inhibition of EC killing 
induced by mixtures of H202 with either SLS or PLC (not shown). In another 
EC model we also inw~stigated the effect of higher amounts of serum on EC 
killing induced by a "super killer cocktail" of agonists (H202, HC10, histone, 
PLC, LL, and trypsin) that might mimic the mixture of agents likely to be 
generated by PMNs in inflamed sites. Such a cocktail had a killing capacity of 
at least five times that reduced by mixtures of peroxide with any of the single 
agonists tested. Figure 9 shows that even in the presence of 40% serum, no 
substantial inhibition of EC killing by the superkiller cocktail occurred unless a 
mixture of antagonists (catalase, taurine, heparin, SBTI, and phosphatidylcho- 
line--an inhibitor of PLC and LL) was also added. These results suggest that 
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Fig. 7. Effect of fetal calf serum (FCS) on killing of endothelial cells by mixtures of CETAB and 
hydrogen peroxide. EC monolayers were exposed either to increasing concentrations of CETAB or 
CETAB + GO (0.2 units/ml). Note that in the presence of 10% fetal calf serum larger amounts of 
CETAB are needed to kill the cells, both in the absence and presence of GO. The data represent 
results of a typical experiment. 
cell injury in inflammatory sites might also be inhibited by such a mixture of  
antagonists administered either systemically or injected locally. 
Release of Arachidonic Acid and Metabolites from EC 
It is well established that an alteration in the integrity of  cell membranes 
occurs when certain microbial products (hemolysins, phospholipases, pore-form- 
ing toxins) as well as snake and bee toxins interact with cells (2, 3, 21). The 
activation o f  membrane-associated PLA2 by a variety of  agonists might also 
result in the release of  AA and its metabolites, as well as in the formation of  
membrane-associated lyso compounds (20). To study whether the killing of  EC 
by the synergistic effects of  oxidants and membrane-damaging agents was also 
accompanied by the solubilization o f  AA and certain of  its metabolites, we 
employed parallel tissue culture plates labeled either with chromium or tritiated 
AA. We treated the cells with a variety of  agonists and determined the solubi- 
lization of  chromium and of  AA. 
Figure 10 shows the time course of  chromium and of  AA release from EC 
treated by combinations of  H20/ ,  PLC, and trypsin. While maximal killing of  
EC was induced by mixtures o f  peroxide and PLC, maximal solubilization of  
AA necessitated the additional presence o f  the proteinase. Similar effects were 
also found when elastase replaced trypsin (not shown). A very marked decrease 
in AA release was observed when either catalase, DMTU, or SBTI were included 
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Fig. 8. Effect of serum on killing of endothelial cells by mixtures of GO + histone. EC were 
exposed for 90 rain at 37~ either to increasing amounts of histone or combinations of GO (0.2 
units/ml) + histone + 10% fetal calf serum. Note that larger amounts of histone are needed to kill 
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Fig. 9. Effect of serum and inhibitors on killing of EC induced by a cocktail of agonists. EC were 
exposed for 90 min at 37~ to a cocktail comprised of GO (0.2 units/ml), histone (100 /zg/ml), 
phospholipase C (0.05 units/:nl), hypochlorous acid (10 4 M),  lysolecithin (5 #g/m1), and trypsin 
(50 #g/ml) and in the presence of increasing concentrations of fetal calf serum. Note that even 40% 
serum failed to significantly inhibit killing of EC by this cocktail of agonists. On the other hand, a 
cocktail of inhibitors comprised of catalase (100 units/ml) soybean trypsin inhibitor (200 #g/ml), 
phosphatidylcholine (500 #g/ml), taurine (1 raM), and heparin (85 units/ml) markedly depressed 
cell killing in the presence of 10-40% serum. The data are the averages of two experiments. 
in the  r eac t ion  mix tu re s  (not  shown) .  F igu re  11 shows  the  d e p e n d e n c y  on  t ryps in  
c o n c e n t r a t i o n  o f  A A  re lease  in the  p r e sence  o f  P L C  and  H202,  aga in  showing  
tha t  all  th ree  agen ts  h a d  to b e  p re sen t  s i m u l t aneous ly  to a ch i eve  m a x i m a l  solu- 
b i l i za t ion  o f  A A .  
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Fig. 10. Time course of the release of chromium (A) and arachidonic acid (AA) (B) from endothelial 
cells treated with a mixture of agonists. Parallel wells of endothelial cells labeled either with 51Cr 
or with [3H]arachidonic acid were treated for 90 min at 37~ either with GO (0.2 units/ml), PLC 
(0.01 units/ml), trypsin (25 #g/ml), or by combinations of GO and PLC, PLC and trypsin, and GO 
+ PLC + trypsin; (A) chromium release; (B) arachidonic acid release. The data are mean value 
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Fig. 11. Dependency on trypsin concentration of the release of arachidonic acid from cells treated 
by GO and PLC. EC labeled with [3H]arachidonic acid were treated for 90 rain at 37~ with 
increasing concentrations of trypsin and with combinations of GO (0.2 units/ml), PLC (0.005 units/ 
ml) and trypsin. The data represent mean values + SD of five separate experiments. 
Figure 12 further shows  that w h i l e  H202 m i x e d  with  LL induced a high 
release o f  c h r o m i u m ,  the additional  presence o f  a proteinase was  needed to 
induce m a x i m a l  so lubi l izat ion o f  A A .  In every case the presence either o f  cat- 
alase,  D M T U ,  Mn 2+, or SBTI very markedly  depressed the release o f  A A  from 
EC (not shown) .  Under  s imi lar  experimental  condit ions ,  mixtures  o f  H202,  SLS,  
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and trypsin also released synergistic amounts of PGE 2 (Figure 13) and mixtures 
of H202 either with PLC or with SLS and with trypsin released synergistic 
amounts of 6-keto-PGF (Figure 14). On the other hand, none of the mixtures 
of agonists tested had file capacity to solubilize significant amounts of throm- 
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Fig. 12. Combined effects of GO, lysolecithin (LL), and trypsin (TPS) on chromium and arachi- 
donic acid release from endcthelial cells. Monolayers of  chromium-labeled and [3H]arachidonic 
acid-labeled EC were exposed for 90 rain at 37~ to increasing concentrations of LL and to mixtures 
of LL with GO (0.2 units/ml) and trypsin (30 tzg/ml). Note that while LL + H202 was sufficient 
to cause maximal cell death, raixtures of  H202 + LL + trypsin were necessary for maximal solubi- 
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Fig. 13. Combined effects o1! H202, streptolysin S (SLS), and trypsin (TPS) on the release of PGE 2 
from endothelial cells. Monolayers of EC were exposed to mixtures of GO (0.2 units/ml), strep- 
tolysin S (50 units/ml), and trypsin (100 tzg/ml). Note that maximal release of PGE2 necessitated 
the simultaneous presence of all three agents. The data represent means values +_ SD of three 
separate experiments. 
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Fig. 14. Combined effects of hydrogen peroxide, PLC, SLS, and trypsin (TPS) on the release of 
6-keto-PG from endothelial cells. Monolayers of endothelial cells in 6-well plates were treated for 
120 min at 37~ with mixtures of GO (0.2 units/ml) with PLC (0.050), SLS (50 units/ml), and 
trypsin (20 #g/ml). Note that maximal release of 6-keto-PG necessitated the simultaneous presence 
of hydrogen peroxide, PLC, or SLS, and trypsin. The data represent mean values + SD of three 
separate experiments. 
Modulation of AA Release by Various Agents 
Effect of Cationic Agents. Cationic agents (histone, PARG, CETAB, 
chlorhexidine) that synergized with H202 kill EC (Figures 1, 2) but failed to 
synergize with H202 to solubilize AA (not shown). It was, therefore, of interest 
to test the possibility that cationic agents might interfere with AA release from 
EC. Cell monolayers were exposed for 15 min to subtoxic concentrations either 
of PARG (5/xg/ml) or CETAB (5/z/ml) and then washed. The cells were then 
exposed to mixtures of  H202 with PLC and trypsin (see Figure 10). We invar- 
iably found that preexposure to cationic agents depressed AA release by 75- 
100% (not shown). These results suggest that cationic agents released either by 
leukocytes or from disintegrating cells in vivo might perhaps modulate the release 
of AA and its metabolites. 
Effect of HClO. HC10 (at 10 -4 M), which failed to synergize with H202 
to kill EC, caused 75% inhibition of AA release when mixed with peroxide, 
PLC, and trypsin (not shown). 
Effect of Tannic Acid. Tannic acid at 10 -5 M caused 90% + 5.0 (N = 
3) inhibition of AA release from EC treated with mixtures of H202, PLC, and 
trypsin and 85% + 4.0 (N = 3) inhibition of AA release with mixtures of  H202 
and trypsin alone. As little as 10 /zl of tea depressed AA release induced by 
mixtures of H202 with PLC and trypsin by about 50 % (not shown). 
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Effect of Quinacrine. The possibility that treatment by agonists that might 
activate a membrane-associated PLA 2 might also release AA was studied by the 
inclusion of quinacrine (a PLA 2 inhibitor) in the reaction mixtures. It was found 
that at 10 -4 M quinacrine depressed AA release from EC treated with mixtures 
of peroxide, PLC, and trypsin by about 50% (not shown). Paradoxically, how- 
ever, quinacrine at this concentration acted synergistically with H202 to kill EC 
(not shown). 
DISCUSSION 
The present experimental model further examines the assumption that cel- 
lular injury that accompanies infectious and inflammatory processes might be 
due, in part, to the synergistic action among oxidants and hydrolases secreted 
either by activated leukocytes, released by disintegrating host cells, or elaborated 
by microorganisms (17, 18, 21). Such agents alter cell viability (14, 15, 17, 
18, 21) and are also instrumental in releasing membrane-associated arachidonic 
acid (AA) and some of its metabolites, which might further modulate the inflam- 
matory processes. 
Our studies suggest that the simultaneous presence of H202 and several of 
the membrane-damaging agents is absolutely essential to secure maximal killing 
of the targets (Figures ~L-3). Histone, SLS, and PLC, at subtoxic concentrations, 
which bind to EC membranes and resist washing, can nevertheless continue to 
synergize with H202 to release radiolabeled chromium (Table 1, Figures 4 and 
12), presumably because of their ability to alter membrane permeability and 
thus to prime the cells for a further oxidant insult (3, 17, 21, 34, 35). 
Since H202 does aot irreversibly bind to membranes (Tables 1 and 2), the 
ability to bind GO (an HzOz-generating enzyme) to mammalian cells by cation- 
ization with PHSTD (Table 2) might serve as a useful tool to enhance cell 
killing in vivo (i.e., tumor cells). Our preliminary findings on the high toxicity 
of cationized OG in tl~e rat lung model is one such an example (29). 
The findings that chlorhexidine, a potent cationic antiseptic widely used in 
dentistry to treat oral lesions, also acts synergistically with H202 to kill EC 
(Figure 2B) suggest that this agent should either not be applied to severely 
inflamed tissue or used in the oral cavities of patients undergoing irradiation of 
the head and neck for treatment of malignancies. The same might be also true 
for the antibiotic polymyxin B (Figure 2A). 
The ability of lysozyme, a distinct bacteriolytic polycation (48) to synergize 
with hydrogen peroxide to kill EC is also important, as inflammatory exudates 
might contain large amounts of this enzyme, which, like other polycations pres- 
ent in inflammatory sites (4, 6, 28), might also amplify oxidant damage, espe- 
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cially in an acidic milieu that increases the cationization of the enzyme. Thus, 
such cationic proteins might also synergize with oxidants, with phospholipases, 
and with microbial hemolysins to kill target ceils, as shown in the present study. 
It might also be speculated that since synergism between SLS and oxidants kills 
EC, other microbial hemolysins and perhaps also the attack complex of com- 
plement (13) might also synergize with oxidants and with proteinase to enhance 
cellular damage. 
The findings that the synergistic killing effect induced by oxidants and 
membrane-active agents was totally inhibited either by scavengers of H202 (cat- 
alase, DMTU, Mn2+), by polyanions, by proteinase inhibitors, or by phospho- 
lipids (Figure 9) also suggest that in in vivo models the administration of adequate 
"cocktails" of antagonists might ameliorate the toxic effects exerted by such 
potentially synergizing agents (Figure 9) (21, 29). 
The ability of 6-deoxyglucose (Figure 5) and puromycin (not shown) to 
markedly enhance the susceptibility of EC to the synergistic killing effects of 
oxidants with PLC or histone but not to H202 alone suggests that the enhanced 
susceptibility was presumably caused by altering complex metabolic pathways 
that might affect the ability of the cells to repair damage caused by H202 (49). 
The interference with calcium balance induced by the calmodulin antagonist 
TFP (Figure 6) (42-44) also markedly enhanced the susceptibility of EC to 
killing by combinations of H202 with membrane-damaging agents. On the other 
hand, neither GTP3'S (a putative antagonist of G proteins), shown to inhibit 
target cell killing by PARG (36), nor TNF, shown to possess a cytotoxic activity 
(38, 39), had any appreciable modulating effects on EC killing. In this respect 
it is of interest that H202 diminished the toxic effects of TNF on targets (40), 
also suggesting that a complex interplay among cytokines, oxidants, and pro- 
teinases might exist in inflamed sites. 
The findings that both tannic acid and extracts of tea, known to be rich in 
this acid, very markedly inhibited both the killing of EC induced by mixtures 
of H202 and PLC or SLS, and the hemolysis of RBC caused either by PLC or 
by SLS, is noteworthy. It further suggests that other cell types, e.g., epithelial 
cells in the gastrointestinal tract, might also be shielded by tannic acid against 
toxins elaborated by gram-negative microorganisms as well as against leukocyte- 
derived oxidants and hydrolases (45-47). 
The inability of deferoxamine to inhibit EC killing induced by the various 
"cocktails" suggests that the OH radical that could have been generated might 
not be involved in our model (37). Experiments to localize a possible presence 
of the OH radical by spin-trapping might resolve this question. 
The findings that rabbit anti-streptococcal IgG acted synergistically with 
H202 to kill EC and the ability of streptococci to adsorb the bulk of the active 
agent present in IgG that synergized with hydrogen peroxide to kill EC are 
intriguing. It points, however, to the possible presence in the anti-streptococcal 
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serum of antibodies cross-reacting with EC (50-52). If, indeed, cytotoxicity was 
caused by such cross-reactive antibodies, it might be the first report to show 
that such potential cytotoxic antibodies might be amplified by a peroxide. It is 
of interest, however, that anti-streptococcal antibodies cross-reactive with heart 
or kidney have never been shown to possess cytotoxic activities either in vitro 
or in vivo (50-52) unless an additional insult, i.e., treatment with isoproteranol 
was given (53) (also a synergistic action?). 
A very important observation described in our study is that, whereas two 
agents (H202 combined with a membrane-damaging agent) were sufficient to 
cause maximal cell death as measured by the chromium release assay (Figures 
1-6, 10A, and 12A), a significant solubilization of AA and several of its metab- 
olites necessitated the additional presence of a proteinase (Figures 10A, 12A, 
13, and 14). It suggests that potent cyclooxygenase products, capable of mod- 
ulating the inflammatou~ responses, can also be released from dead cells abun- 
dantly present in inflamed sites. It is also suggested that both the measurements 
of lipid and chromium release from cells yield better information on the mech- 
anism of cell damage. The findings that none of the agonists tested were capable 
of releasing significant amounts of thromboxane B2 is not understood and further 
studies on this issue are warranted (55). 
The role of H202 as a low-level releaser of arachidonic acid from a variety 
of mammalian cells was recently reported (25, 54-56). One study (25) showed 
that even millimolar concentrations of peroxide failed to release any substantial 
amounts of labeled AA from macrophages. Another study (55) showed that 
H202 was capable of solubilizing some 6-keto-PGFt and thromboxane B2 from 
targets. This was strongly inhibited by quinacrine (a PLA2 inhibitor). Our study, 
however, is the first report showing that a proteinase is necessary for the solu- 
bilization of large amounts of AA from EC treated by mixtures of H202 with 
cytolytic agents (PLC, LL, SLS). 
The cardinal rote played by proteinases in AA release, as shown in the in 
vitro model, implies that a similar phenomenon might also occur in inflammatory 
sites known to contain all the necessary agonists capable of causing cell death 
and probably also the release of membrane lipids possessing potent pharmaco- 
logical properties. 
However, not all the membrane-active agents tested were capable of syner- 
gizing with H202 and with a proteinase to release AA from EC. Cationic agents, 
which, together with H::O2, killed EC (Figures 1-3), failed to release any appre- 
ciable amounts of AA. Furthermore, cationic agents (PARG, chlorhexidine, 
CETAB) very markedly inhibited the release of AA from the injured cells induced 
by mixtures of oxidants with membrane-damaging agents and with a proteinase. 
Inhibition by cationic agents might be due to their ability to interact electro- 
statically with anionic sites (sialic acid, acid phospholipids) present on cell 
surfaces. They might also inactivate membrane-associated enzymes that partic- 
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ipate in lipid release (21). Other potent inhibitors of AA release from EC are 
quinacrine (an inhibitor of PLA2), HC10, which might oxidize surface com- 
ponents, and tannic acid and tea extracts, which are known to denature proteins 
and which were also shown to inhibit lysis of RBC by PLC and SLS. 
Taken together, our findings suggest that sublethal injuries induced in mam- 
malian cells, either by oxidants that interfere with cell metabolism and inhibit 
repair of minor cellular damage (57-61) or by membrane-damaging agents (21), 
can be greatly amplified by mixtures of the two types of agonists. Cellular 
destruction might further be augmented if proteinases and other proinflammatory 
agents are also present. The detailed mechanisms by which oxidants, membrane- 
damaging agents, and proteinases injure and kill mammalian cells has recently 
been reviewed in detail (12, 21, 57-62), and this issue is beyond the scope of 
the present communication. 
Our studies with the EC model in culture might open new avenues to 
elucidate the mechanisms of tissue destruction in vivo. The data in Figure 9 
indicate that serum proteins might not hinder the synergistic effects of a mixture 
of agonists likely to be present in inflamed sites. Furthermore, adequate cocktails 
of antagonists might prove beneficial for the prevention of the synergistic killing 
and lipid-releasing capacities of leukocyte products. Such cocktails of antago- 
nists might also prove beneficial in preventing tissue damage in ischemia and 
reperfusion (62) as well as in a variety of other inflammatory conditions and 
their sequelae. 
Finally, current studies from our laboratories (submitted for publication) 
have also shown that EC exposed to subtoxic amounts of a variety of pesticides 
(lindane, parathion, malathion) were also killed in a synergistic manner by 
subtoxic mixtures of oxidants and membrane-damaging agents. These agents 
also released substantial amounts of AA. It is suggested, therefore, that the 
synergy phenomenon described in our communications (17, 18, 21) is probably 
universal. 
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